Benjamin Hohl

Insider Reports History

Location
Boulder, CO
Signature
/s/ Benjamin Hohl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Hohl:

Company Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 61,000 $1,548,180 $25.38 12 Feb 2026 Direct
Enliven Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 150,000 12 Feb 2026 Direct

Insider Reports Filed by Benjamin Hohl

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 12 Feb 2026 2 $0 4 CHIEF FINANCIAL OFFICER 17 Feb 2026, 19:49
ELVN Enliven Therapeutics, Inc. 22 Dec 2025 2 +$32,240 4 CHIEF FINANCIAL OFFICER 23 Dec 2025, 18:47
ELVN Enliven Therapeutics, Inc. 29 Sep 2025 3 -$58,231 4 CHIEF FINANCIAL OFFICER 01 Oct 2025, 16:46
ELVN Enliven Therapeutics, Inc. 27 Aug 2025 3 -$58,979 4 CHIEF FINANCIAL OFFICER 29 Aug 2025, 17:03
ELVN Enliven Therapeutics, Inc. 28 Jul 2025 4 -$58,444 4 CHIEF FINANCIAL OFFICER 30 Jul 2025, 17:57
ELVN Enliven Therapeutics, Inc. 10 Jul 2025 3 -$20,175 4 CHIEF FINANCIAL OFFICER 14 Jul 2025, 17:07
ELVN Enliven Therapeutics, Inc. 27 Jun 2025 4 -$59,896 4 CHIEF FINANCIAL OFFICER 01 Jul 2025, 16:42
ELVN Enliven Therapeutics, Inc. 13 Jun 2025 3 -$60,215 4 CHIEF FINANCIAL OFFICER 17 Jun 2025, 16:24
ELVN Enliven Therapeutics, Inc. 27 May 2025 3 -$44,533 4 CHIEF FINANCIAL OFFICER 29 May 2025, 17:38
ELVN Enliven Therapeutics, Inc. 28 Apr 2025 4 -$52,678 4 CHIEF FINANCIAL OFFICER 30 Apr 2025, 18:59
ELVN Enliven Therapeutics, Inc. 27 Mar 2025 3 -$61,261 4 CHIEF FINANCIAL OFFICER 31 Mar 2025, 19:37
ELVN Enliven Therapeutics, Inc. 24 Mar 2025 3 -$20,024 4 CHIEF FINANCIAL OFFICER 26 Mar 2025, 19:37
ELVN Enliven Therapeutics, Inc. 04 Mar 2025 2 +$24,800 4 CHIEF FINANCIAL OFFICER 06 Mar 2025, 18:02
ELVN Enliven Therapeutics, Inc. 27 Feb 2025 3 -$58,267 4 CHIEF FINANCIAL OFFICER 03 Mar 2025, 20:07
ELVN Enliven Therapeutics, Inc. 06 Feb 2025 1 $0 4 CHIEF FINANCIAL OFFICER 10 Feb 2025, 17:27
ELVN Enliven Therapeutics, Inc. 05 Feb 2025 3 -$20,044 4 CHIEF FINANCIAL OFFICER 07 Feb 2025, 19:06
ELVN Enliven Therapeutics, Inc. 27 Jan 2025 3 -$62,118 4 CHIEF FINANCIAL OFFICER 29 Jan 2025, 19:21
ELVN Enliven Therapeutics, Inc. 27 Dec 2024 6 -$83,934 4 CHIEF FINANCIAL OFFICER 31 Dec 2024, 17:18
ELVN Enliven Therapeutics, Inc. 13 Dec 2024 5 +$9,681 4 CHIEF FINANCIAL OFFICER 07 Jan 2025, 16:43
ELVN Enliven Therapeutics, Inc. 27 Nov 2024 4 -$117,668 4 CHIEF FINANCIAL OFFICER 02 Dec 2024, 17:18
ELVN Enliven Therapeutics, Inc. 28 Oct 2024 4 -$162,985 4 CHIEF FINANCIAL OFFICER 30 Oct 2024, 18:04
ELVN Enliven Therapeutics, Inc. 18 Oct 2024 3 -$22,404 4 CHIEF FINANCIAL OFFICER 22 Oct 2024, 16:19
ELVN Enliven Therapeutics, Inc. 04 Oct 2024 6 -$287,524 4 CHIEF FINANCIAL OFFICER 08 Oct 2024, 18:56
ELVN Enliven Therapeutics, Inc. 01 Oct 2024 3 -$13,055 4 CHIEF FINANCIAL OFFICER 03 Oct 2024, 18:44
ELVN Enliven Therapeutics, Inc. 27 Sep 2024 6 -$138,329 4 CHIEF FINANCIAL OFFICER 01 Oct 2024, 19:53
ELVN Enliven Therapeutics, Inc. 27 Aug 2024 3 -$85,242 4 CHIEF FINANCIAL OFFICER 29 Aug 2024, 18:36
ELVN Enliven Therapeutics, Inc. 31 Jul 2024 3 -$24,823 4 CHIEF FINANCIAL OFFICER 02 Aug 2024, 19:23
ELVN Enliven Therapeutics, Inc. 29 Jul 2024 4 -$127,032 4 CHIEF FINANCIAL OFFICER 31 Jul 2024, 19:31
ELVN Enliven Therapeutics, Inc. 12 Jul 2024 3 -$67,755 4 CHIEF FINANCIAL OFFICER 16 Jul 2024, 17:34
ELVN Enliven Therapeutics, Inc. 27 Jun 2024 5 -$85,382 4 CHIEF FINANCIAL OFFICER 01 Jul 2024, 20:03
ELVN Enliven Therapeutics, Inc. 28 May 2024 5 -$87,990 4 CHIEF FINANCIAL OFFICER 30 May 2024, 17:54
ELVN Enliven Therapeutics, Inc. 03 May 2024 3 -$20,020 4 CHIEF FINANCIAL OFFICER 07 May 2024, 18:58
ELVN Enliven Therapeutics, Inc. 29 Apr 2024 3 -$47,105 4 CHIEF FINANCIAL OFFICER 01 May 2024, 19:02
ELVN Enliven Therapeutics, Inc. 11 Apr 2024 4 -$311,429 4 CHIEF FINANCIAL OFFICER 15 Apr 2024, 19:04
ELVN Enliven Therapeutics, Inc. 27 Mar 2024 4 -$51,242 4 CHIEF FINANCIAL OFFICER 29 Mar 2024, 17:59
ELVN Enliven Therapeutics, Inc. 27 Feb 2024 3 -$47,103 4 CHIEF FINANCIAL OFFICER 29 Feb 2024, 17:27
ELVN Enliven Therapeutics, Inc. 13 Feb 2024 1 $0 4 CHIEF FINANCIAL OFFICER 15 Feb 2024, 20:54
ELVN Enliven Therapeutics, Inc. 29 Jan 2024 3 -$43,328 4 CHIEF FINANCIAL OFFICER 31 Jan 2024, 21:20
ELVN Enliven Therapeutics, Inc. 28 Dec 2023 9 -$148,889 4 Chief Financial Officer 02 Jan 2024, 19:59
ELVN Enliven Therapeutics, Inc. 22 Dec 2023 6 -$14,223 4 Chief Financial Officer 27 Dec 2023, 17:26
ELVN Enliven Therapeutics, Inc. 04 Apr 2023 1 $0 4 Chief Financial Officer 06 Apr 2023, 20:32
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Chief Financial Officer 27 Feb 2023, 20:33
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Chief Financial Officer 27 Feb 2023, 20:25